LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 1Jai Radhe Sales
03 1Virupaksha Organics
04 1HRV Global Life Sciences
05 1Venkar Chemicals
06 2Arch Pharmalabs
07 2Aurobindo Pharma Limited
08 1Aurore Life Sciences
09 3Cipla
10 1Curia
11 1DEAFARMA
12 1Derivados Quimicos SAU
13 1Dr. Raju’s Pharma Solutions
14 1Esteve Quimica
15 1H. Lundbeck AS
16 2Hetero Drugs
17 1Heumann
18 1Ipca Laboratories
19 1Jiangsu Jiwa Rintech Pharmaceutical
20 1Jiangsu Nhwa Pharmaceutical
21 2Jubilant Generics
22 2Jubilant Pharmova
23 1Kekule Pharma
24 1Mahban Group
25 2Natco Pharma
26 1Nishchem International Pvt. Ltd
27 1Raks Pharma
28 1Shodhana Laboratories Pvt. Ltd
29 1Smilax Laboratories Limited
30 1Sumitomo Chemical
31 2Sun Pharmaceutical Industries Limited
32 1Synergene Active Ingredients Pvt Ltd
33 1Tianish Laboratories
34 2Viatris
35 2Wockhardt
36 1Wuxi Jida Pharmaceutical
37 1Zhejiang Huahai Pharmaceutical
Reset all filters
01 4China
02 1Denmark
03 1Germany
04 32India
05 1Iran
06 1Italy
07 1Japan
08 2Spain
09 5U.S.A
Reset all filters
01 16Active
02 12Inactive
03 20Blank
01 14Valid
02 34Blank
Reset all filters
01 48Blank
Reset all filters
01 1WC-0040n
02 1WC-0066
03 1WC-0091n
04 1WC-0092
05 1WC-0119
06 1WC-0120
07 1WC-014
08 1WC-0141
09 1WC-0143n
10 1WC-0144nA2
11 1WC-014n
12 1WC-0168
13 1WC-0230
14 1WC-0359
15 34Blank
Reset all filters
01 48Blank
Reset all filters
01 147621-022
02 151686-0007
03 155486-1572
04 159349-0010
05 163850-3616
06 164220-105
07 165015-721
08 165372-1101
09 165372-1130
10 165862-336
11 165977-0018
12 165977-0053
13 172761-006
14 184206-0022
15 34Blank
01 48Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-12-17
Pay. Date : 2023-06-05
DMF Number : 36925
Submission : 2023-05-22
Status : Active
Type : II
Certificate Number : R0-CEP 2021-437 - Rev 00
Issue Date : 2023-08-29
Type : Chemical
Substance Number : 2288
Status : Valid
NDC Package Code : 51686-0007
Start Marketing Date : 2024-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : EU DMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23979
Submission : 2010-07-19
Status : Active
Type : II
Certificate Number : R1-CEP 2011-214 - Rev 00
Issue Date : 2017-09-14
Type : Chemical
Substance Number : 2288
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-08-15
Pay. Date : 2023-08-11
DMF Number : 20586
Submission : 2007-06-04
Status : Active
Type : II
Certificate Number : R1-CEP 2010-037 - Rev 01
Issue Date : 2020-07-17
Type : Chemical
Substance Number : 2288
Status : Valid
NDC Package Code : 64220-105
Start Marketing Date : 2011-02-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17511
Submission : 2004-07-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20094
Submission : 2006-12-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17104
Submission : 2004-01-13
Status : Inactive
Type : II
98
PharmaCompass offers a list of Citalopram Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Citalopram Hydrobromide manufacturer or Citalopram Hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Citalopram Hydrobromide manufacturer or Citalopram Hydrobromide supplier.
PharmaCompass also assists you with knowing the Citalopram Hydrobromide API Price utilized in the formulation of products. Citalopram Hydrobromide API Price is not always fixed or binding as the Citalopram Hydrobromide Price is obtained through a variety of data sources. The Citalopram Hydrobromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Citalopram Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Citalopram Hydrobromide, including repackagers and relabelers. The FDA regulates Citalopram Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Citalopram Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Citalopram Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Citalopram Hydrobromide supplier is an individual or a company that provides Citalopram Hydrobromide active pharmaceutical ingredient (API) or Citalopram Hydrobromide finished formulations upon request. The Citalopram Hydrobromide suppliers may include Citalopram Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Citalopram Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 37 companies offering Citalopram Hydrobromide
Get in contact with the supplier of your choice: